Pratley RE, Kang J, Trautmann ME, et al
Understanding your genetic predispositions helps PlexusDx clinicians select whether compounded semaglutide injection, oral semaglutide, tirzepatide, or the GLP-Squared dual compound is most likely to deliver weight loss results for your body
Meanwhile, the frenzy over retatrutide has kicked into even higher gear since the Phase 3 results were announced this month
While weight loss doesn't replace MS drugs, managing weight through diet, exercise, and medications like GLP-1 agonists may lead to fewer relapses, less disability, and better responses to standard drug treatments by reducing systemic inflammation, he says
Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: new frontiers in metabolic dysfunction-associated steatotic liver disease therapy